N-oleyl-L-dopa

N-oleyl-L-dopa is a lipophilic amide derivative of L-dopa (levodopa) designed as a prodrug for the treatment of Parkinson's disease. By conjugating L-dopa with an oleyl fatty acid chain, the molecule's lipophilicity is significantly increased, which is intended to enhance blood-brain barrier penetration and provide a sustained-release effect. Research has demonstrated its utility as a structure-directing agent in the synthesis of mesoporous silica nanoparticles (MSNs). These drug-templated nanoparticles have shown improved therapeutic efficiency in mouse models of Parkinson's disease compared to conventional L-dopa, potentially offering a way to mitigate the motor fluctuations and dyskinesia associated with long-term standard therapy.

Other names

N-oleoyl-L-dopaN-oleyl-L-DOPAN-oleoyl-levodopa